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Unlike a number of amyloid-forming proteins, stefins, and in particular stefin B (cystatin B)
form amyloids under conditions where the native state predominates. In order to trigger
oligomerization processes, the stability of the protein needs to be compromised, favoring
structural re-arrangement however, accelerating fibril formation is not a simple function
of protein stability. We report here on how optimal conditions for amyloid formation
lead to the destabilization of dimeric and tetrameric states of the protein in favor of
the monomer. Small, highly localized structural changes can be mapped out that allow
us to visualize directly areas of the protein which eventually become responsible for
triggering amyloid formation. These regions of the protein overlap with the Cu (II)-binding
sites which we identify here for the first time. We hypothesize that in vivo modulators
of amyloid formation may act similarly to painstakingly optimized solvent conditions
developed in vitro. We discuss these data in the light of current structural models of stefin
B amyloid fibrils based on H-exchange data, where the detachment of the helical part and
the extension of loops were observed.
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INTRODUCTION
The mechanism of amyloid fibril formation by human stefins A
and B and their chimeras has been studied extensively by our
groups (Kenig et al., 2006; Jelinska et al., 2011; Žerovnik et al.,
2011). While stefin B amyloids have not been observed directly
in vivo, mutations in the gene encoding stefin B cause a progres-
sive form of Myoclonus Epilepsy (Unverricht-Lundborg disease
or EPM 1) and it has been proposed that these mutations corre-
late with their aggregation behavior in vitro (reviewed in Polajnar
et al., 2012). Compared with its better recognized partner cys-
tatin C, which causes a hereditary cerebral amyloidosis, it is more
readily available for biophysical work and, as such, has been
extensively used as a workingmodel. While structural studies have
focused on the amyloid endpoint (Morgan et al., 2008), kinetic
studies have led to a proposed model for the amyloidogenesis of
stefin B (Skerget et al., 2009). This protein was shown to conform
to other globular amyloid forming proteins in both the morphol-
ogy of final amyloid fibrils and in the early appearance of the
prefibrillar oligomers which range from dimers, tetramers, and
hexamers to higher oligomers—such as 8-mers, 12-mers, 16-mers
to even 32-mers (Ceru et al., 2008). These oligomers have been
extensively studied and proved to behave as other “amyloid tox-
ins,” interacting with lipid membranes and even making pores
(Ceru et al., 2008; Rabzelj et al., 2008).
Knowledge of the aggregation behavior of proteins, partic-
ularly in the context of the formation of fibrous amyloid-like
structures, has widened our original simplistic unimolecular view
of the energy landscape for a protein (Dobson, 2003; Eichner
and Radford, 2011). Although the original hypothesis proposed
by Levinthal (1969), that a protein folding pathway must exist,
is still valid, the complexity of this pathway and our ability to
define it have been challenged. Amyloid is an aggregate that
invariably requires a substantial structural re-arrangement within
the naturally occurring protein precursor (Jarrett and Lansbury,
1993; Wetzel, 1996; Rochet and Lansbury, 2000). It is pertinent
to the current study, that we should examine the mechanism
through which proteins from the cystatin family, and in our
example, stefin B (also referred to as cystatin B) is channeled
down alternative folding routes.
Current thinking supports the idea that the folding of small
regions may be significantly important in fibril formation. In pro-
tein folding the nucleation condensation model (Fersht, 1995)
suggests that only a small number of contacts may be required
to initiate protein folding. In the protein aggregation field,
the idea of amyloidogenic determinants (the minimal regions
required for fibril formation) predominates and the arrange-
ment of very short sequences is believed to drive the forma-
tion of fibrils (Conchillo-Sole et al., 2007; Tartaglia et al., 2008;
Maurer-Stroh et al., 2010). Local disturbances that are inde-
pendent of or uncoupled to the folding of the protein as a
whole may lead to alternative folded states. This type of non-
cooperative behavior has been observed before in the folding
of “uncoupled proteins,” where removal of a core interaction
causes folding in small regions at a time [e.g., apomyoglobin
(Staniforth et al., 2000) and Ca2+-free α-lactalbumin (Schulman
et al., 1997)].
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The alternative hypothesis is that simply destabilizing the
native fold by shifting the equilibrium of unfolding would be
sufficient to induce fibrillization. This hypothesis is not sup-
ported when calculations of fibrillization propensity are con-
ducted (Chiti et al., 2003). These calculations necessarily include
many parameters with the ability to form β-sheet structure being
the most influential. Also mutational studies on stefin B show
that the stability of the protein does not correlate with its fibril-
lization propensity (Kenig et al., 2006).
In this work, we use NMR spectroscopy to examine struc-
tural changes in soluble forms of stefin B. Under the conditions
of biochemical experiments, where Stefin B concentrations are at
least 1μM, the protein naturally populates different oligomeric
states and the recombinant protein is obtained as a mixture of
monomers, dimers, and tetramers from E. coli. We report here
on the multistate nature of the dimeric form of the protein,
which is believed to be the precursor to amyloid. We then map
out regions of the protein which are perturbed when the pro-
tein is incubated under the amyloidogenic conditions which have
been optimized in vitro (Zerovnik et al., 2002). Finally we com-
pare these artificial conditions to the effects of the divalent metal
Cu (II) which is known to interact with stefin B (Zerovnik et al.,
2006).
MATERIALS AND METHODS
PROTEIN AND AMYLOID FIBRIL PRODUCTION
Our Stefin B construct (C3S, with glutamate polymorph at posi-
tion 31) was transformed into E. coli BL21-DE3 cells and was
purified according to Rabzelj et al. (2005) and Morgan et al.
(2008). Stefin B amyloid fibrils were grown from 30μM soluble
protein by incubating at 30◦C in 15mM sodium acetate buffer,
pH 4.7, containing 150mM NaCl and 10% trifluoroethanol
(TFE). CuSO4 was added according to the ratios indicated to a
final concentration of 15μM, 30μM, and 60μM. Fibril growth
over time was monitored by adding thioflavine T to a final
concentration of 10μM (Naiki and Gejyo, 1999). Fluorescence
spectra (λex = 442 nm and λem = 482 nm) were recorded on a
Shimadzu RF-5301PC (Shimadzu, Japan) or a VarianCary Eclipse
(Agilent, UK). The fluorescence amplitudes of the reactions were
normalized as the presence of Cu (II) affects the total fluores-
cence value. Because the formation of amyloid fibrils by stefin
B is largely independent of protein concentration (Skerget et al.,
2009), time courses were fitted to a single exponential increase
to determine the elongation rate of the fibrils. Lag times were
deduced from the cross-over point with the x-axis. All data
manipulation and fitting was carried out using GraFit, Version
3.0 (Erithacus Software Ltd.).
SIZE-EXCLUSION CHROMATOGRAPHY (SEC)
The oligomeric state of protein samples was analyzed using a
KW-803 size exclusion column (Shodex, Japan) attached to a
Perkin Elmer Series 200 HPLC system with a UV absorbance
detector. The buffer used was 50mM sodium phosphate buffer,
100mM NaCl, pH 7, 1mM NaN3 for native samples and
while pH titrations were carried out in 15mM sodium acetate,
150mM NaCl, 1mM NaN3 at a range of pHs between 6.0
and 4.7.
NMR SPECTRA
Samples for NMR in native conditions were made by adding
2H2O [final concentration 10% (v/v)] to a 500μl sample
with a uniformly labeled 15N protein concentration of 200μM
(monomer equivalents), as determined by UV absorption, in
10mM sodium phosphate buffer (pH 6) and containing 100mM
NaCl (the conditions in which it was purified by gel-filtration
chromatography). pH titrations were carried out in 15mM
sodium acetate buffer 100mMNaCl at a range of pHs between 6.0
and 4.7. All spectra were recorded at 25◦C on Bruker DRX spec-
trometers operating at proton frequencies of 500MHz, 600MHz,
or 800MHz, using either room temperature or cryogenically
cooled triple-resonance probes. A combination of in-house and
standard Bruker pulse programs was used. NMR data were pro-
cessed using Felix 2000 and Felix 2004 software (Accelrys, CA,
USA) running in-house macros.
ASSIGNMENT OF THE CYSTATIN B DIMER 1H15N HSQC SPECTRUM
Samples were made up as above but protein concentrations were
1mM and both 15N and 13C labeling of the protein was required.
NMR backbone resonance assignment was carried out as previ-
ously described (Morgan et al., 2008). Where extra peaks compli-
cated the assignment procedure in which we used the “Asstools”
software (in-house program of the Leicester University Biological
NMR centre), it was necessary to determine which peaks were
equivalent—representing the same residue—by comparing their
carbon chemical shifts. Peaks near to each other which had very
similar sets of carbon cross-peaks were likely to represent the same
amide, especially if their positions were similar to the assigned
peak from the 1H15N HSQC spectrum of the monomer. The
duplicate peaks were excluded from the spin system list. This
strategy allowed the peak list to be reduced to a more manageable
number, and most of the residues have been assigned. The excep-
tions are glycine 60, glutamate 62, and aspartate 63, although
aspartate 61 is still identifiable. That these peaks are missing
is consistent with the exchange broadening associated with the
conformation of glycine 60, lysine 33, and aspartate 63 described.
pH AND TFE TITRATIONS
Proton and nitrogen chemical shifts for each residue were
extracted from 1H15N HSQC spectra and peak position change
was calculated with respect to peak position at pH 6.0, 0% TFE.
A threshold for significance was set to be two times the average
line width (width of the peak in ppm) at 50% peak height. This
value is 0.075 ppm for proton and 0.56 ppm for nitrogen chemical
shifts. Data for the movement of peaks in the dimeric form show
the average of the absolute movement for each residue as most
residues display at least two peaks in the 1H15NHSQC spectra. So
that movements in opposite directions do not cancel each other
out the absolute values formovement were used during data anal-
ysis and the movement of multiple peaks was averaged to a single
value.
Cu (II) TITRATIONS
The peak heights for assigned residues were extracted from 2D
1H15N-HSQC spectra of a Cu (II) titration experiment for both
the monomeric and dimeric states of stefin B. Since there is an
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overall reduction in peak height it is necessary to decide what
is classed as a larger than normal loss in peak height. To decide
upon this, the standard deviation of the mean peak height loss of
all residues was calculated and all data greater than one standard
deviation of the mean were taken as significant.
CIRCULAR DICHROISM
Equilibrium unfolding of stefin B was monitored at a range of
CuSO4 concentrations (ratios of 0:1, 1:1, and 5:1 Cu (II): protein).
50μM protein solutions were prepared at a range of guanidine
hydrochloride (GdnHCl) concentrations in fibrillization buffer
minus the TFE (15mM sodium acetate pH4.7, 150mM NaCl).
Circular Dichroism spectra were recorded at 25◦C on a Jasco
810 spectropolarimeter (Jasco, Japan) and the titration data fitted
according to Jelinska et al. (2011).
RESULTS
STEFIN B IN SOLUTION IS A MIXTURE OF MONOMER, DIMER
AND TETRAMER
As shown before (Ceru et al., 2008) recombinant stefin B is puri-
fied from E. coli as a mixture of monomer, dimer, and tetramer.
The monomeric state is only meta-stable under most experimen-
tal conditions (ionic strength > 100mM, 6.5 < pH < 8.0) and
will readily form dimers within minutes (Zerovnik et al., 1997;
Kenig et al., 2006; Jelinska et al., 2011). Because of the unusual
3D domain-swapped nature of the dimers, it is unlikely that
the dimers can revert back to monomers without first undergo-
ing an unfolding reaction (Scheme I, Jerala and Zerovnik, 1999;
Staniforth et al., 2001). Tetrameric forms of the wild-type stefin
B protein can be purified but re-equilibrate over a time-scale of
15 h at room temperature to a mixture in which they populate
only a minority fraction (Jenko Kokalj et al., 2007) even at artifi-
cially high protein concentrations (>4mM). Under a chosen set
of conditions, the population of any particular oligomeric state of
stefin B is therefore a competition between the rates of unfolding,
dimerization, and folding. This has been quantified for another
more amenable cystatin from chicken egg white (Sanders et al.,
2004).
Previous work reported that the NMR spectra of the folded
states of stefin B are very similar, indicating that the basic fold of
the protein is not significantly changed between the monomer,
dimer, and tetramer (Jenko Kokalj et al., 2007; Morgan et al.,
2008). The changes observed between monomeric and dimeric
stefin B map onto the regions of the structure involved in dimer-
ization by 3D-domain swapping, with the largest changes around
the loop between strands 2 and 3, which forms the hinge loop in
the domain-swapped structure of stefin A. Other residues whose
chemical shifts change substantially form the interface between
the two domains of the dimer and include the loop between
strands 4 and 5 (for e.g., Figure 4B). This is reminiscent of
changes observed for its homolog, stefin A, upon dimerization
(Jerala and Zerovnik, 1999; Staniforth et al., 2001). Chemical shift
differences between the dimer and tetramer of stefin B occur
in the same regions as those observed between the monomer
and dimer where further structural changes lead to tetramer
formation (Jenko Kokalj et al., 2007).
In this study, we were interested inmapping structural changes
observed when the protein is induced to fibrillize into amyloid.
We therefore examined the oligomeric state of the protein under
our experimentally optimized conditions (Zerovnik et al., 2002)
which are mildly acidic (pH 4.7) and contain 10% TFE, a sol-
vent which is known to aid fibrillization (Chiti et al., 1999),
presumably because of its dual nature as both a denaturant and
a secondary structure stabilizing agent. These conditions were
those used in our previous structural characterization of stefin B
amyloid and are pertinent here.
Figure 1A shows the ratio of monomeric to dimeric stefin B
under the near-native conditions in which it is purified (in blue)
and as the pH is lowered to pH 4.7 and TFE titrated to 10%
(in red). Although the error on the data is high (±0.25), it is of
note that the ratio of monomers to dimers is observed consis-
tently to increase from a 1:1 to a 2:1 ratio. This is because although
the dimeric form of the protein may be energetically more stable
than the monomer; the two species never reach equilibrium. In
order to understand why this is, it is useful to consider that the
system is composed of more than just two states (Scheme I).
Under fibrillization conditions, the population of unfolded states
FIGURE 1 | Oligomeric state of stefin B under fibrillization conditions
in vitro. (A) Changes in the apparent ratio of monomer to dimer as the
protein is taken from physiological pH (pH 6.0, in blue) to conditions which
favor fibrillization in vitro (pH 4.7, in red). The ratio of monomer and dimer is
calculated from amide peak intensities for three residues (Q71, L73, and
E76) showing well-resolved NMR signal changes in the 2D 1H15N HSQC.
Under the conditions of the experiment, we estimate the error to be ±0.25.
(B) A single point mutation (P79S) causes the stabilization of the tetrameric
state of stefin B in solution at pH 7.0 (Jenko Kokalj et al., 2007). Fibrillization
conditions optimized in vitro cause dissociation of the tetramer to a mixture
of dimer and monomer close to WT, which explains how this mutant
remains a slow fibrillizing species.
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(U) has been shown previously to increase greatly and can com-
prise up to 1% of the sample (Zerovnik et al., 1998, 1999, 2007;
Jelinska et al., 2011). Increasing the unfolding rate of dimers (red
arrow) will allow a greater population of foldedmonomeric states
to accumulate at any point in time:
U M
M∗
D
M∗
⇌
(Scheme I)
As the dimer D unfolds to form U, it dissociates and then
always forms the monomer M more rapidly than it can dimer.
This is simply because any part of a protein chain is more likely
to find its intramolecular partner residues before those in a
different molecule unless the protein concentration in solution
exceeds ∼10mM (estimate of effective concentration according to
Creighton, 1993). As was proposed for its chicken cystatin coun-
terpart (Sanders et al., 2004), and based on current data for our
stefin B protein, we can hypothesize that the formation of the
dimer requires the coming together of two, relatively rare, par-
tially folded states of the protein (M∗) in an orientation that is
“assembly-competent.”
The tetrameric state of the wild-type protein is only a minor
component at the temperatures greater than 20◦C used here for
NMR so we exploited the effect of a mutation at proline 79
to serine (P79S) in order to examine the effect of fibrillization
conditions on this oligomeric form of stefin B. This mutation
favors the tetrameric form of the protein and in fact allowed crys-
tallization and structural determination of this state previously
(Jenko Kokalj et al., 2007). Figure 1B shows the effect of low-
ering the pH to 4.7 on this oligomeric form of the protein as
measured using size-exclusion chromatography. The elution peak
shifts suggesting there is structural exchange on the timescale
of the experiment. Importantly, at pH 4.7, the P79S stefin B
variant shows a profile where there is no detectable tetrameric
stefin B in solution and the dimeric form predominates. The
tetrameric form of stefin B has been suggested as a precursor to
amyloid formation but under the fibrillization conditions used
in vitro at least, this state is not populated significantly. This is
also the case for other variants of this protein where the tetrameric
forms remain undetectable under fibrillization conditions, unlike
its homolog from chicken egg white (Sanders et al., 2004 and
manuscript in preparation).
To conclude, the principle forms of stefin B populated under
our in vitro fibrillization conditions (pH 4.7 and 10% TFE) are
monomers and dimers. We will therefore focus on these molecu-
lar species of stefin B to examine early structural changes leading
to fibril formation.
MULTIPLE STATES IN THE DIMER
Proteins in solution do not have a fixed, rigid structure, but
are flexible, dynamic molecules, which can adopt many different
conformations. The NMR signal or chemical shift of a partic-
ular nucleus depends on the conformation of the protein. If
the protein has a single structure which it occupies most of the
time, then the observed chemical shift will correspond to that
structure. If, however, the nucleus sees more than one environ-
ment, corresponding to different protein conformations, then the
different chemical shifts will contribute to the spectrum. The
major influences on amide chemical shifts in proteins are residue
conformation, hydrogen bonding and nearby aromatic groups.
The dispersion of proton chemical shifts in a 2D 1H15N-HSQC
NMR spectrum is mainly due to hydrogen bonding patterns
defined by secondary structure.
The 2D 1H15N-HSQC spectrum of the dimer of stefin B shows
unusual features which are not shared with other oligomeric
forms of the protein. A large proportion of the residues in
the protein have more than one peak attributable to them
(Figure 2A). How a residue’s conformations influence its NMR
spectra depends on the rate at which the protein changes its
conformation. Most local fluctuations within proteins occur too
quickly to observe directly by looking at different chemical shifts.
However, if the change in conformation is slow compared to the
chemical shift difference (generally less than 10 per second, a half-
time of 100ms), then the conformations can produce discrete
peaks, if the difference in chemical shifts is large enough to be
resolved. The discrete peaks seen in the spectrum of the dimer
(Figure 2A) suggest that the protein populates at least four dis-
tinct conformations, and the exchange rates between these states
are slow, indicating large energy barriers between them. An alter-
native explanation is that the protein forms an asymmetric (and
therefore probably not 3D domain-swapped) dimer. However,
only a third of the protein’s residues have more than one peak,
which suggests that much of the structure is the same for the two
domains (Figure 2B).
Looking at the residues which have several peaks (Figure 2A),
it is possible to observe patterns in the distribution of the peaks.
Generally, there seem to be four peaks for each of the “split” spin
systems, which generally have the same carbon shifts, suggest-
ing that the structure at these positions is similar. Glycine 50 is
a good example of the pattern of peaks; it seems to be a dou-
blet of doublets, suggesting that there are two distinct changes
causing the four populations. The pattern is repeated for sev-
eral other residues, including S3, S7, and F98. The existence
of small but significant energy barriers between the different
species and this splitting behavior is reminiscent of the behavior
of residues located near proline residues where flexible structure
allows cis-trans isomerization processes to occur.
LOWERING THE pH
In 2D 1H15N-HSQC experiments, peak positions (chemical
shifts) are highly sensitive to changes in the chemical environment
of the corresponding residue. We used this experiment to detect
even small changes in the structure of monomers and dimers as
fibrillization conditions are titrated in. To start with, we carried
out a pH titration. This was done in small pH steps (∼0.3–0.4
pH units) to allow peak movements to be tracked with confi-
dence, but even then, some peaks moved beyond the point that
they could be followed. N77 and H75 became indefinable for
the monomeric and dimeric structures respectively between pH
5.0 and pH 4.7. Large movements like this are generally due to
changes in protonation state as a result of moving though the
intrinsic pKa of particular residues.
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FIGURE 2 | Multiple HSQC peaks in the spectrum of the stefin B dimer.
(A) Pattern of multiple peaks in the HSQC spectrum. To illustrate, the four
peaks assigned to each of methionine 2 (left), serine 7 (centre) and glycine
50 (right) suggest that two conformational changes (labeled A and B) can
account for the four states. (B) The number of peaks in the HSQC are
plotted against residue number. (C) Residues with multiple peaks are
colored blue in the structure of the dimer (bottom). (D) Multiple HSQC
peaks around proline 36. In this view of the stefin B monomer (PDB code
1STF), residues with multiple peaks (and proline 36) are blue; other peaks
are red. Proline 36 is in the trans conformation, and isomerization could
affect the conformation of residues 37–39, as well as arginine 24, which
packs against phenylalanine 38. The resulting two structures could give
rise to the two peaks seen for each blue residue in the HSQC spectrum of
the dimer. (E) Multiple HSQC peaks around strands 4 and 5. The loop
between the two C-terminal β-strands of stefin B is part of the protease
binding site, and is flanked by two proline residues at positions 74 and 79.
Cis-trans isomerism in proline 79 could be the cause of the multiple peaks
observed on strand 5, which could in turn affect phenylalanine 98. The two
prolines, and residues which have multiple peaks in the HSQC spectrum of
the dimer are blue; other residues are red.
Whereas six residues display significant movement in either
proton or nitrogen chemical shift in the spectrum of the
monomeric stefin B, for the dimeric structure, a larger number
of residues are seemingly affected by the pH titration com-
pared to the monomeric state. Four residues show significant
nitrogen chemical shift change while nine show significant proton
chemical shift change. Of the five additional residues highlighted
in the dimer compared to the monomer, two (62 and 63) do not
have assignments in the monomeric form (so no data is available
on their movement) while two (64 and 93) show large proton
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chemical shift changes (−0.074 and 0.071 respectively) that lie
just under the threshold of 0.075 set for this data. For these rea-
sons, only the dimer structure is shown in Figure 3A to illustrate
these effects.
There are two regions within the monomeric form showing
significant change during the pH titration from pH 6.0 to pH 4.7.
The change in residues L73, E76, and N77 can be explained by
the protonation of residue E76. The locations of E76 and L73 in
the monomer suggest the possibility of a hydrogen bond between
them, but due to flexibility in this region the crystal structure
cannot give the exact positions of these residues. Protonation of
E76 would prevent the hydrogen bond from forming. Without
the constraining hydrogen bond, E76 could move out into solu-
tion, changing the dihedral angle of the peptide backbone, which
in turn will alter the chemical shift of N77. Also, the protonation
of E76 would affect the nitrogen chemical shift of N77, which is
reflected in the data. The proton chemical shift of N77 will be
affected by N-H bond rearrangement.
The change in proton chemical shift of the other region
(88–93) will be the result of N-H dihedral bond angle change
and not protonation since the nitrogen chemical shifts are not
affected. There is already flexibility in the loop regions (reflected
by quite large b-factors in the crystal structure (PDB 1STF, Stubbs
et al., 1990) so slight rearrangements will not alter the overall fold
of the protein.
In the dimeric structure, the region around E76 is again
affected by chemical shift change in nitrogen and proton dimen-
sions, as a result of protonation of the glutamic acid at position
76. L73 is not in the correct orientation in the dimer to form a
hydrogen bond with E76 so is not affected. There is an increase in
the number of affected residues in the 88–93 region in the dimer
compared to the monomer. This will be in response to changes in
the geometry of the N-H bonds in this region because only proton
chemical shifts are affected.
Residues 62–64 show significant chemical shift change in the
dimer but not in the monomer, this is because of the lack of
an assignment for these residues in the monomer rather than
a different behavior occurring in the monomer. Residues 62–64
are displaying chemical shift change because of the glutamic and
aspartic acid residues in the region. The most likely candidate for
protonation is residue D63 since this and the following residue
(F64) both display a change in nitrogen chemical shift. This may
result in them becoming more solvent exposed, thus in turn alter-
ing backbone dihedral angles explaining the H chemical shift
change in E62 and F64.
Overall the areas in the monomer and dimer affected by
dropping the pH from 6.0 to 4.7 are the same. The chemical
shift changes observed are restricted to the mobile loop regions
between strands 3 and 4, 4 and 5 and the C-terminus. There
is thus no evidence for large scale (global) structural changes
associated with a partially folded intermediate state.
EFFECT OF TRIFLUOROETHANOL (TFE) ON THE NATIVE STEFIN B
STRUCTURE
Previously, circular dichroism data (Zerovnik et al., 1999) sug-
gested that concentrations of TFE lower than 15% v/v have little
or no effect on the folded state of the protein. The concentration
FIGURE 3 | How in vitro fibrillisation conditions affect the structure of
the stefin B dimer (pdb code 2OCT). (A) The effect of lowering the pH
from 6.0 to 4.7. (B) The effect of titrating in 10% TFE at pH6.0. (C) The
effect of combining these two effects and transferring the protein to
fibrillisation conditions, pH4.7, 10% TFE. The residues of stefin B that are
significantly affected are shown as spheres with a radius proportional to the
change in chemical shift observed (0.075–0.2 ppm in proton shift or 0.55–1
ppm nitrogen shift). Purple spheres represent residues with significant
change in both proton and nitrogen chemical shifts while red and blue
represent residues with significant change in proton or nitrogen only
chemical shifts respectively.
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of TFE in the fibrillization buffer used for stefin B is 10% v/v.
Without the addition of TFE, the fibrillization process takes
months instead of weeks to occur (Zerovnik et al., 2002).
To investigate the possibility of minor structural alterations
being propagated by the addition of TFE, 2D 1H15N-HSQC spec-
tra were recorded for a titration from 0 to 10% TFE at pH 6.0.
TFE has very little effect on the chemical shifts of the monomer.
Four residues show significant change in the nitrogen dimen-
sion (E29, V41, V48, and S83) but no residues show significant
change in proton chemical shift. When these residues are plot-
ted onto the structure they are not confined to a specific region
or structural element, nor are they amino acids of similar chem-
istry suggesting these effects are unlikely to be truly significant.
Inspection of data collected on the dimer shows TFE has a more
significant effect on the dimeric state of stefin B. Six residues show
chemical shift change in both dimensions, three show nitrogen
chemical shift change only and three show proton change only
(Figure 3B). There is an obvious cluster around the extended
β-sheet between the two domains of the domain swapped dimer,
comprising strands 2 and 3 of the original monomer fold. This
region shows chemical shift change in both proton and nitrogen
dimensions suggesting large structural changes in this region may
be occurring. This region has great flexibility which could eas-
ily cause significant chemical shift change. Other than this region,
residues showing change are scattered around the rest of the struc-
ture and are probably the result of localized structural changes in
loop regions. Other than the flexibility in the extended β-strand
region (comprising strands 2 and 3), there is very little chem-
ical shift change, suggesting that there is no structural change
occurring to the general fold of the dimer.
Overall, it can be concluded that the change in chemical shift in
the extended β-strand region is the result of destabilization of that
region, which in turn causes a destabilization of the dimeric form
(Figure 1A). This area is the “hinge” region which bridges the two
cystatin fold units in the 3D domain-swapped dimers of cystatin
B. Destabilized dimers most likely dissociate then refold back to
a monomeric form which is less affected by the presence of TFE
(see Scheme I in earlier section). This provides a structural expla-
nation for the observation of dimer dissociation upon addition of
TFE (section “Stefin B in solution is amixture of monomer, dimer
and tetramer”).
EFFECT OF THE COMBINATION OF REDUCING pH AND THE
ADDITION OF TFE ON NATIVE STEFIN B
The effect of reducing the pH and adding TFE on the structure of
stefin B has been assessed on an individual basis in the previous
two sections. However, the conditions required for stefin B fibril-
lization call for a combination of decreased pH and addition of
TFE. To check that this combination does not alter the structure
of stefin B to a larger degree than the conditions individually, the
chemical shifts for the monomer and dimer were extracted from
an 1H15N HSQC spectrum of stefin B in 15mM sodium acetate
pH 4.7, 10% v/v TFE. The chemical shifts from this spectrum
were compared to the chemical shifts at pH 6.0, 0% v/v TFE. The
monomeric form has a total of 15 residues exhibiting a signifi-
cant chemical shift change while the dimeric form has 22. Plotting
these residues onto the structures of the stefin B monomer and
dimer shows dispersion of the residues across the structure of the
monomeric form, although they could be said to be loosely con-
fined to the loop regions at the ends of the β-strands. The dimeric
form shows the same pattern and is thus shown for illustration in
Figure 3C. Extensive chemical shift change is localized to the ends
of loops, but with the addition of the extended β-sheet region
between the two domains of the dimer (strands 2 and 3).
MAPPING THE EFFECT OF Cu (II)
Previous work showed that stefin B monomer and dimer, both
of the wild type (WT) E31 and a Y31 variant, bind Cu (II) ions
(Zerovnik et al., 2006), whereas the tetramer (P79S) did not bind
this ion. Divalent metal ions such as Cu (II), Zn (II), and Fe (II)
are observed to be co-localized in amyloid plaques in vivo. The
concentration of these metals is often much higher than nor-
mally found within the human body, ∼400μM, ∼1mM, and
∼1mM for Cu (II), Zn (II), and Fe (II) respectively (Curtain et al.,
2001). This massive increase in localized concentration has led to
the hypothesis that these metals are bound by the mature amy-
loid fibrils and that they may influence the formation of amyloid
fibrils.
NMR was used to perform 2D 1H15N-HSQC experiments to
identify regions within the native stefin B oligomers (monomer
and dimer) that bind, or are close to the binding sites of Cu (II).
Cu (II) has a very definite effect when looking at protein by NMR
due to its paramagnetic nature. When a protein binds Cu (II), the
lone electrons interfere with the magnetic dipoles in close vicinity.
This shields them from the magnetic field generated by the NMR
magnet and so causes them to become undetectable by solution
NMR. We therefore identified the specific residues that are close
to the Cu (II) binding site by monitoring their disappearance in a
series of 2D 1H15N-HSQC spectra collected at increasing CuSO4
concentrations (ratios of Cu (II):protein 0.5:1–2:1).
Figures 4A and B shows that there are three main regions in
the monomeric state of stefin B that display a large reduction in
peak height relative to the average change. These regions when
modeled on the monomeric stefin B structure show two possi-
ble Cu (II) binding regions. Residues 15–22 which are within the
α-helix facing away from the β-sheets form a likely binding area
together with residues around the loop region of 75–77 (between
β-strands 4 and 5). There are many residues within these two
areas that are capable of binding a metal such as Cu (II), these
being Glu15, His18, and Gln22 in the helix and His75, Glu76,
and Asn77 in the loop region between β-strands 4 and 5. At first
glance these regions seem too far apart to form a singular bind-
ing domain but the flexibility in the loop region where His75
is located may allow sufficient movement to bring the two his-
tidine residues (18 and 75) together, and along with the other
possible ligands in that region could form a site for Cu (II) coor-
dination. The second possible Cu (II) binding region combines
the residues at the C-terminal (90–94) with residues in the loop
between β-strands 3 and 4 (residues 62–64). This site is not well
defined in the monomeric 1H15N-HSQC data due to the lack of
an assignment for residues 62 and 63, but when this binding site is
looked at in the dimeric structure, where the assignment is avail-
able for this region, the data support these residues as belonging
to this second binding site.
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FIGURE 4 | Mapping copper binding sites in soluble stefin B.
(A) Changes in the relative intensity of amide NMR signals upon Cu2+
binding (calculated from the 2D 1H15N HSQC spectra). The dashed
lines represent one (red) and two (orange) standard deviations from
average intensity changes measured in solution. Changes above
standard deviation are deemed to be significant. (B) Residues with
significant changes are plotted in orange on the structures of the stefin
B monomer and dimer. Histidine residues that are within these regions
are drawn in red and are shown in stick form to highlight their
position.
The equivalent peak height data for the dimeric state is shown
in Figure 4A. The dimeric state shows a greater number of
residues with reduced peak intensity compared to the monomer,
though many of these are in the same area as in the monomer.
The two loop regions containing residues 62–64 and 90–94 show
a significant height loss in the spectra obtained on the addition
of Cu (II). As mentioned previously there are multiple residues
capable of binding Cu (II) in this region, again confirming the
likelihood of these two regions forming a binding site. This
is particularly obvious when viewed on the dimeric structure
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(Figure 4B). Residues 72–76 also show significant height reduc-
tion, similar to the monomer, but in the dimeric structure it
appears that it no longer forms a binding site with the α-helix
preferentially. The dimer shows an extra region (residues 45–51)
that in the monomer is in the loop between β-strands 2 and
3 but in the dimer form the elongated β-strand that joins the
two domains of the domain-swapped dimer. This region shows
a greater number of residues displaying significant peak height
change in the dimer than the α-helix does and so appears to
replace the α-helix in forming a Cu (II) binding site with residues
72–76. There are also a few residues in the N-terminus that may
contribute to this binding site, though they may just be in the
vicinity of the bound Cu (II) ion. It is unclear why the elongated
β-strand region (residues 45–51) would be a strong binding site
for Cu (II) because there is a distinct lack of residues within that
region capable of binding ametal ion (only Ser45 and Thr51). It is
also worth noting that there is a slight alteration of the residues in
the loop between β-strands 4 and 5 participating in Cu (II) bind-
ing shifting in the dimer when compared to the monomer. There
is a shift toward residues close to the elongated β-strand (residues
72 and 73 in the dimer compared to residue 77 in the monomer).
The two possible binding sites that have been proposed here
appear to have similar affinities for Cu (II). This can be deduced
from the peak reductions during titration. If binding sites of
unequal affinities were present the first site would bind up to
a 1:1 stoichiometry [stefin B:Cu(II)] the second binding site
would then be populated and become visible. In this data both
binding sites appear simultaneously and so both must have sim-
ilar affinities. This agrees with the previously published data
(Zerovnik et al., 2006) which proposes two binding sites with
picomolar affinities for Cu (II) (Ka = 7.2 × 1010 M−1 and Ka =
1.0 × 1010 M−1).
The specific regions of binding are thus defined andmost likely
incorporate residues other than the histidines proposed in previ-
ous work. We show here that His18 (monomer only), His75 and
His92 are involved in Cu (II) binding but that His58 and His66
are not. We also show that there is a different Cu (II) binding
mechanism employed by different oligomeric states of the protein
(monomer and dimer). Unfortunately this data does not allow
us to map specific interactions of Cu (II) binding because of the
number of flexible loop regions involved. This means that exact
residue side chain positions cannot be identified, only the region
in which the Cu (II) has bound.
Cu (II) RETARDS THE ELONGATION OF STEFIN B FIBRILS
Metal ions have different effects on different amyloid-forming
proteins. Some studies find that metal ions speed up the rate of
fibrillization or reduce the lag phase while others report that it
retards the fibrillization process and in some cases can stop the
process occurring completely (Atwood et al., 1998; Zou et al.,
2001; Raman et al., 2005). The fibrillization time course of stefin
B in the presence of Cu (II) was monitored using thioflavine T
fluorescence. In order to interpret our results when comparing
with the reaction in the absence of Cu (II), we first measured
the effect of Cu (II) on the monomer and dimer structures
of the protein under in vitro fibrillization conditions using 2D
NMR spectroscopy (1H15N-HSQC). Although lowering the pH
must affect the protonation of a number of residues identified
as involved in coordinating Cu (II), the NMR peak intensities of
stefin B are affected by Cu (II) in exactly the same way as seen
under the more native pH conditions discussed in the previous
section (data not shown). This confirms that both Cu (II) bind-
ing sites are retained at pH 4.7, most likely because protonation
of coordinating residues is not yet significant.
The fibrillization time course of stefin B shown in Figure 5A
shows that Cu (II) retards the reaction by slowing the elon-
gation phase of the reaction very significantly. The elongation
rate constant ke reduces by a factor of 10 from 1.9 × 10−5 s−1
in the absence of Cu (II) to 2.1 × 10−6 s−1 at a stoichiometric
concentration of Cu (II). As Cu (II) is increased to a 2:1 (Cu
(II):protein) stoichiometry, ke does not change. The lag phase
shows a slight change as Cu (II) is added but at its maximum are
only 2-fold different to WT and so not a large enough difference
to be significant.
Since above a ratio of 1:1 (Cu (II):protein) there is little or no
increase in the effect on the rate of fibrillization, this suggests that
the binding of Cu (II) during the fibrillization process is in a 1:1
stoichiometry. In the native form, at both pH 6.0 and 4.7, it has
already been shown in this study that Cu (II) has two binding
sites. If Cu (II) was altering the fibrillization kinetics through an
interaction with the native form it would be assumed that Cu (II)
would have maximal effect on the fibrillization process at a 1:2
stoichiometry. Therefore the effect of Cu (II) on the ke of the fib-
rillization process may not be due to its interaction with the native
form but instead its interaction with some other, partially folded
form that has only a single Cu (II) binding site.
Cu (II) FAVORS AN UNFOLDED STATE OF STEFIN B
To investigate the possibility that Cu (II) is interacting with a
form of stefin B other than the natively folded one, the stability
of stefin B with increasing concentrations of Cu (II) was investi-
gated. The denaturing agent Guanidine hydrochloride (GdnHCl)
was titrated into solutions of stefin B in the presence of increas-
ing amounts of Cu (II) and circular dichroism used to detect
changes in the fold of stefin B. The retardation of the fibrilliza-
tion reaction may be due to the binding to and stabilizing of the
native form by Cu (II) and so increasing the energy required to
unfold to the appropriate degree to allow initiation of fibrilliza-
tion. Alternatively, Cu (II) may be binding to another form of the
stefin B and by binding is in turn stabilizing this form. There is
a good chance, due to the fibrillization conditions being so close
to the unfolding point of stefin B, that this unknown state is par-
tially unfolded. Figure 5B shows the denaturation curve of WT
stefin B along with the fitted parameters. At pH 4.7, stefin B is
only marginally stable and at this pH has a very low midpoint
of unfolding at 0.49M GdnHCl. When Cu (II) is added we see
that the unfolding curve is moved left, to a midpoint of unfold-
ing of 0.32M and 0.24M GdnHCl denaturant activity for 50μM
and 250μMCu (II) (ratios of 1:1 and 5:1 Cu(II):protein) respec-
tively. This suggests that Cu (II) is actually destabilizing the native
structure at pH 4.7 rather than stabilizing it. The reduction in
the midpoint of unfolding values during the titration (Figure 5B)
suggests that Cu (II) is interacting with a partially folded or an
unfolded form of stefin B under fibrillization conditions and
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FIGURE 5 | The effect of Cu (II) on fibril formation. In (A) the formation of
stefin B fibrils is monitored using Thioflavine T fluorescence at 482nm
(λexcitation = 442nm). The ratio of Cu (II) to protein is 0:1 (open circles), 0.5:1
(open squares), 1:1 (open triangles, up) and 2:1 (open triangles, down). The
fibrillization of the mutant stefin B V59Q, where the equivalent point mutation
to that seen in the amyloid disease-causing homolog, cystatin C (L68Q) is
shown for comparison (closed circles). Solid lines represent data fitting to a
single exponential increase. Elongation rate constants ke are 1.9× 10−5 s−1
in the absence of Cu (II) and 2.5× 10−6 s−1 in the presence of saturating
amounts. For the mutant V59Q (closed circles), the lag time is reduced 5-fold
from 20 hours to 4 hours, whereas the elongation rate constant ke is
increased to 8 x 10−5 s−1. In (B), the effect of Cu (II) on the stability of the
folded state of stefin B under fibrillization conditions (15mM sodium acetate,
150mM NaCl, 10% TFE, pH4.7). The ratio of Cu(II):stefin B protein is 0:1
(open circles), 1:1 (open triangles, up), 5:1 (closed triangles). The calculated
stabilities of the protein expressed as the free energy difference GF/U is
−3.3, −2.2 and −1.7 kcal mole−1 respectively. Cu (II) binds preferentially and
stoichiometrically to an unfolded form of stefin B, such that the observed
slowing down of the fibrillization reaction in the presence of Cu (II) cannot
come about through the stabilization of the folded state.
therefore that it is not the stabilization of the natively folded state
that is retarding the fibrillization process. Electron microscopy
data confirm that the fibrils produced in the absence and presence
of Cu (II) have similar morphology (data not shown).
DISCUSSION
So what changes could be responsible for producing different
precursor states? The work presented here highlights particu-
lar regions of the stefin B protein that are affected at the local
level when conditions that either favor or hinder amyloid fib-
ril formation are titrated in. Under all the conditions monitored
here, the overall structure of the stefin B retains its native fold
and therefore the structured areas are less sensitive to the titra-
tions than the more intrinsically flexible loops. We will consider
here how changes in these loops may trigger secondary structure
re-arrangements and eventually lead to new tertiary folds.
THE ROLE OF THE HELIX (RESIDUES 13–33)
Previous work (Janowski et al., 2001; Staniforth et al., 2001;
Morgan et al., 2008) on stefin B and other cystatins has shown
that the displacement of the helix from the β-sheet is key to the
formation of dimers and amyloid fibrils. In fact the hereditary
amyloidosis associated with cystatin C (Palsdottir et al., 1988;
Levy et al., 1989) is caused by a point mutation at position 68
which is thought to weaken the interaction between the helix
and the β-sheet (Janowski et al., 2001). This position is aligned
with valine 59 in the stefin B protein studied here (Rawlings and
Barrett, 1990). Mutating this residue to glutamine in the same
way causes a V59Q protein with accelerated fibrillization kinet-
ics compared to that of the WT (Figure 5A) while it is otherwise
structurally very similar. Although in vivo effectors of fibril-
lization appear to directly affect the helix, can the fibrillization
conditions used in vitro be having a similar effect?
Cu (II) is observed to bind to two regions of the protein and
one of these sites changes when the protein dimerizes (Figure 4).
In the monomeric form of the protein, Cu (II) binds between the
helix and the loop between strands 4 and 5 (residues 75–77). As
the protein dimerizes, the helix alters this interaction and its sig-
nificance in the binding of Cu (II) is lessened. The loop between
4 and 5 is now involved in forming a site with residues in the loop
between strands 2 and 3 (residues 45–51) which becomes part
of an elongated β-strand. This change in focus for metal-binding
reflects on the helix, a key area important for both dimerization
and fibrillization reactions.
The mechanism by which modifications in this area may
specifically lead to fibrillization must be a combination of events
but most probably starts with an increased flexibility in the loops
either end of the helix. It is notable in this optic, that both the
N-terminal and the loop between the helix and strand 2 con-
tain proline at positions 6, 11, and 36. Just as the other two
prolines in the protein, these residues are in the trans conforma-
tion in the crystal structure of the monomer, but may isomerize
in solution, especially during the partial unfolding involved in
dimerization. Proline 6 is in the unstructured N-terminal region
(Figure 2B), and nearby residues show two peaks in the NMR
spectrum of the monomer. This may be responsible for the mul-
tiple peaks for the N-terminal residues in the dimer (Figure 2C),
although the effect is more pronounced in this form of stefin B,
suggesting that another process may be involved. It is possible that
isomerization of proline 11 is also playing a role. Proline 36 is
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in a loop region between the α-helix and the second strand of
the β-sheet. Several nearby regions have multiple peaks, and the
packing of these residues is shown in Figure 2D. Most of these
residues have two peaks in the 1H15N-HSQC spectrum, so pro-
line isomerization could account for both of these. In support of
a role for these regions is the observation that a mutant stefin B
(G4R) associated with the degenerative form of epilepsy EPM-1
has a 4-fold longer lag phase (Rabzelj et al., 2005). Also, a possible
polymorph of stefin B where glutamate at position 31 is replaced
by a tyrosine retards fibrillization while destabilizing the native
state substantially (Kenig et al., 2006).
THE C-TERMINAL (RESIDUES 90–98) AND THE LOOP BETWEEN
STRANDS 3 AND 4 (RESIDUES 60–62)
The family I cystatins or stefins contain a very short sequence
(three residues) between strands 3 and 4 unlike the family II cys-
tatins such as cystatin C, where an extended, disulphide-bridged
loop is present (22 residues). The work presented here highlights
this region in the protein as affected by the mildly acidic con-
ditions necessary for fibrillization (Figure 3A) but also a key to
Cu (II) binding in monomers and dimers within a site possi-
bly involving nearby residues in the C-terminal (Figure 4). Again
this latter part of the protein is different in the stefins, where
compared with the single residue observed in the family II cys-
tatins, this area of the protein is an extended conformation with
restricted chain flight (nine residues), where the backbone of the
terminal residue 98 loops back to hydrogen bond with the side
chain amide of residue 84 in strand 5 (Stubbs et al., 1990; Jenko
Kokalj et al., 2007; Morgan et al., 2008). However in all cystatins,
albeit in different ways, these regions are close enough to affect
each other, and together with the loop between strands 4 and
5 may be important in modulating the structural outcome of
strands 4 and 5.
THE DOMAIN-SWAPPING “HINGE” REGION (RESIDUES 45–51)
3D domain-swapping in the cystatin proteins involves the forma-
tion of dimers where the cystatin fold is retained but is made of
two different polypeptide chains. Residues 1–47 are contributed
by one chain while residues 48–98 from a separate chain make
up the remainder of the fold (Janowski et al., 2001; Staniforth
et al., 2001; Jenko Kokalj et al., 2007). The “hinge” bridging the
2 cystatin folds is the former active site loop of the protease
inhibitor (residues 45–51) which now relaxes into an extended
β-sheet structure. Strands 2 and 3 of the original fold now form
an unusually long, continuous β-strand which is 20 residues
long (residues 37–57). This feature of the dimers appears to be
retained in the amyloid fibrils made from stefin B (Morgan et al.,
2008) where protection from hydrogen-exchange and therefore
secondary structure can be mapped to the whole length of this
strand. This part of the molecule also contains the regions with
the highest degree of amyloidogenicity according to predictor
programs (for e.g., Conchillo-Sole et al., 2007; Tartaglia et al.,
2008; Maurer-Stroh et al., 2010), with residues central to strand
3 (and to a lesser extent to strand 5) are identified as likely to be
core to the new amyloid structure.
It is intriguing therefore that the hinge region core to this
structure is strongly affected by fibrillization conditions. As
explained in the previous section, Cu (II) favors binding to the
dimeric conformation of this hinge (Figure 4C) whereas the amy-
loidogenic solvent TFE destabilizes it (Figure 3B). This suggests
that although this regionmay be retained in a dimer-like extended
β-strand conformation in the amyloid fibrils, flexibility in this
region is required to enable successful assembly of amyloid. This
would be the case for example if propagated 3D domain-swapping
were the key to assembly as proposed for human cystatin C
(Wahlbom et al., 2007) but also supports any model requiring
significant further tertiary re-arrangements (Morgan et al., 2008).
Although discounted as the least likely proposition, it is for-
mally possible that the hinge region in stefin Bmay be responsible
for the multiple discrete peaks observed in the dimer NMR spec-
trum (1H15N HSQC) of stefin B (Figure 2). Constraints on the
flexibility of the hinge, unlike in its stefin A counterpart where
there appears to be none, may be restricting the conforma-
tional space available to the protein as it assembles into larger
oligomers.
THE ROLE OF THE LOOP BETWEEN STRANDS 4 AND 5 (RESIDUES 71–79)
The residues that have been identified to stabilize the tetrameric
form have also been identified as the residues showing chemical
shift change in fibrillization conditions (Figures 3 and 4). In fact,
the whole loop involved in the “hand shaking” tetramerization
interface containing residues P74 and H75 (Jenko Kokalj et al.,
2007) is likely to be altered under fibrillization conditions since
residues in the loop 72–79 display chemical shift change. In order
to interpret the effect of these changes, it is important to consider
the role of the prolines at positions 74 and 79. A trans- to cis-
isomerization of the backbone amide bond at the conserved pro-
line 74 position is thought to be key to the formation of the new
inter-dimer interface created in the tetramer.
The mutation of two proline residues (74 and 79) to serine
creates proteins which both display altered characteristics (Jenko
Kokalj et al., 2007; Smajlovic´ et al., 2009). One allows the stabiliza-
tion of tetrameric form (P79S) while the other (P74S) drastically
slows the kinetics of fibrillization. These results taken together
implicate the conformation of the loop containing residues 72–79
as having a major influence in the oligomerization of stefin B.
Cu (II) is shown to retard elongation of fibrillization of stefin B
and is shown to interact with the loop containing P74 and P79 in
both monomeric and dimeric stefin B. Data presented in Figure 5
suggest that a further modification of this site, although slowed
by the presence of Cu (II) may result in a new interaction with Cu
(II) which stabilizes unfolded forms of stefin B (Figure 5B) and
eventually fibrillar forms (Figure 5A). At the same time, protona-
tion of Histidine 75 is key to changes observed in the protein as
the pH is lowered and favors fibrillization reactions.
Prolines 74 and 79 are on either side of the second active site
loop and are likely to be the source of the multiple peaks observed
in strand 5 of the dimer (Figures 2B andC). They could represent
the alternate conformations of the β-strands and the intervening
loop when one, both or neither proline is in the cis conformation.
The single peaks observed for residues in the loop itself could be
due to the flexibility of the loop causing conformational averaging
in this region. As shown in Figure 2E, perturbations in strand 5
would also affect the conformation of phenylalanine 98, whose
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side chain packs against the aliphatic part of the side chains of
asparagine 84 and aspartate 86.
THE ROLE OF DIFFERENT STRUCTURAL STATES IN THE DIMER OF
STEFIN B
It is possible that all the multiple peaks observed may be due to
alternative packing arrangements of the both N-terminal region
and the loop between strand 4 and 5, which in turn are governed
by the conformation of the proline residues in these regions. The
single peaks observed in the spectrum of the tetramer suggests
that this species populates a single form (or that conformational
averaging results in single peaks) possibly selected from one of the
dimer conformations.
The regions of the stefin B dimer which have multiple peaks
in its 1H15N HSQC spectrum (Figures 2B and C) are similar to
those that show a conformational change between the monomer
and tetrameric crystal structures. The two active site loops of the
monomer appear to be able to access several conformations, and
it is these regions which are important in the tetramerization
reaction. It is possible that a particular conformation of these
regions is necessary for dimers to associate into tetramers, and
that only a subset of dimer conformations (perhaps one of the
four states observed in solution) can form tetramers. Since the
multiple states in the dimer appear to be due to proline isomer-
ization, which is also responsible for the orientation of the loop
between strands 4 and 5, then this process may well control the
dimer-tetramer equilibrium.
It is possible that similar arguments may be valid regarding the
ability of the dimer to assemble into amyloid fibrils if the tetramer
represents a “dead-end” in a reaction that can otherwise propa-
gate. This view is supported by data on chicken cystatin, where
indistinguishable unimolecular processes (rearrangement within
the dimer) are rate-limiting for the dimer to tetramer and dimer
to amyloid fibril reactions (Sanders et al., 2004 and manuscript
in preparation). However, without more detailed kinetic data
on this process for stefin B, it is not possible to confirm this
hypothesis.
The theory of uncoupled protein folding/unfolding being
involved in the fibrillization is not just confined to stefin B.
Other proteins that form amyloid fibrils do so under destabiliz-
ing but non-denaturing conditions, conditions that could easily
destabilize some regions more than others, leaving particular
interactions required for fibrillization intact. For example, the
fibrillization of β2-microglobulin at pH 3.6 occurs above the
midpoint of unfolding for this protein (McParland et al., 2000).
However, looking specifically at this protein, the incorporation
of Cu (II) induces fibrillization at physiological pH (Eakin and
Miranker, 2005). This has been shown to be due to interactions of
Cu (II) with a specific region inducing the formation of a native
like structure that retains its high β-sheet content but has alterna-
tive conformations in localized loop regions (Eakin et al., 2006).
This region is also a loop containing a proline residue which has
striking parallels with the observations reported here. This all
confirms the importance of localized regions and shows that con-
ditions that induce fibrillizationmerely help the protein adopt the
required conformational change more frequently.
CONCLUSION
Viewing these results as a whole suggests that the zigzag inter-
action of loop regions (particularly the loop 72–79) may be
responsible for bringing multiple stefin B protein chains together.
During this time uncoupled unfolding, particularly the detach-
ment of the α-helix, may occur. This partially unfolded but
possibly still domain-swapped dimeric core structure may repre-
sent the nucleus of the fibrillization process. This would allow the
interaction of the β-sheet region of multiple stefin B chains result-
ing in the initiation of amyloid formation or in the attachment
to an existing fibril. The interaction of the β-sheet of multiple
protein chains would leave the helix excluded and exposed to the
solvent which is consistent with the proposed structural model
of stefin B fibrils (Morgan et al., 2008). However, not all loop
conformations would adapt easily to the growing fibril. A selec-
tion would be made from the conformations divided by relatively
high energetic barriers of proline isomerization between cis or
trans. For example, in the tetramer only the cis isomer of P74
is allowed (Jenko Kokalj et al., 2007). Similarly, some specific
isomeric state could be fixed in the fibrils. This further under-
lines the proposed role for peptidyl prolyl isomerases (PPIs) in
amyloid diseases (Eakin et al., 2006; Jahn et al., 2006; Pastorino
et al., 2006; Ryo et al., 2006). This suggests prolines act as
switches between off-pathway oligomers and on-pathway fibrillar
states.
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